NCT04636957 - A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE) | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

July 31, 2022

Conditions

Acute Otitis Externa

Interventions

DRUG

Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution

0.25mL/vial, each vial contains 0.75mg of ciprofloxacin and 0.0625mg of fluocinolone acetonide.

DRUG

Ciprofloxacin 0.3% solution

0.4mL/vial, each vial contains 1.2mg ciprofloxacin

Trial Locations (1)

Eye & Ent Hospital of Fudan University, Shanghai